Effects of treatment with nilvadipine on cerebral ischemia in rats.
The protective effects of a Ca2+ antagonist, nilvadipine, on focal cerebral ischemia were studied in male spontaneously hypertensive rats. The animals received either nilvadipine (3mg x kg(-1) x day(-1)) or a vehicle subcutaneously. Group 1 (n=11) was treated for 7 days, and Group 2 (n=11) for 14 days. The middle cerebral artery was occluded on the 6th (Group 1) or 13th (Group 2) day of the treatment, and neuropathological outcomes were quantified 24 hours later. The mean arterial blood pressure was significantly reduced with nilvadipine to normal levels. The % infarct volumes of Groups 1 (37+/-2) and 2 (34+/-3) were significantly less than those of their controls (39+/-3 [n=11] and 40+/-4 [n=12], respectively), although the difference between Groups 1 and 2 was not significant. When infarct areas were compared in each of 8 coronal sections, the infarct size had decreased in the 5 posterior sections in Group 2, but only in 2 sections of Group 1. A significant decrease in the edema volumes was observed in Group 2, but not in Group 1. Thus, nilvadipine provided protective effects against cerebral ischemia in rats having chronic hypertension, and the effects were dependent on the duration of treatment.
Kawamura
S
S
Department of Surgical Neurology, Research Institute for Brain and Blood Vessels-AKITA, Japan.
Li
Y
Y
Shirasawa
M
M
Yasui
N
N
Fukasawa
H
H
D000818:Animals; D000959:Antihypertensive Agents / Q000097:blood / Q000627:therapeutic use*; D001921:Brain / Q000473:pathology; D002121:Calcium Channel Blockers / Q000097:blood / Q000627:therapeutic use*; D002544:Cerebral Infarction / Q000473:pathology / Q000517:prevention & control; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D002546:Ischemic Attack, Transient / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D008297:Male; D009543:Nifedipine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use; D051381:Rats; D011918:Rats, Inbred SHR; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; C035100:nilvadipine; D009543:Nifedipine